Pharming Group NV Strategic Asset Allocation Index
Pharming Group NV strategic asset allocation index. Pharming Group NV (PHAR) has a Strategic Asset Allocation Index of 3.1% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $8.65 Million) total $8.65 Million, measured against net assets of $277.02 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Pharming Group NV (PHAR) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Pharming Group NV (2017–2025)
Strategic asset allocation index of Pharming Group NV from 2017 to 2025. This chart shows how Pharming Group NV's Strategic Asset Allocation Index has evolved across 9 annual periods from 2017 to 2025. As of December 2025, the index stands at 3.1%, representing strategic assets of $8.65 Million against net assets of $277.02 Million USD. Check tangible equity quality of Pharming Group NV to evaluate the tangible quality of the company's equity base.
Pharming Group NV Strategic Asset Allocation Index by Year (2017–2025)
Pharming Group NV strategic asset allocation index by year from 2017 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Pharming Group NV from 2017 to 2025, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Pharming Group NV market cap and net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 3.1% | $8.65 Million | $- | $8.65 Million | $277.02 Million | ▲ +1.2 pp |
| 2024 | 1.9% | $4.23 Million | $- | $4.23 Million | $221.06 Million | ▼ -2.8 pp |
| 2023 | 4.8% | $10.40 Million | $- | $10.40 Million | $218.78 Million | ▼ -19.1 pp |
| 2022 | 23.9% | $48.88 Million | $39.15 Million | $9.73 Million | $204.64 Million | ▲ +4.2 pp |
| 2021 | 19.7% | $38.05 Million | $29.26 Million | $8.79 Million | $192.92 Million | ▲ +4.1 pp |
| 2020 | 15.6% | $23.43 Million | $17.63 Million | $5.80 Million | $150.16 Million | ▼ -1.5 pp |
| 2019 | 17.1% | $20.04 Million | $14.53 Million | $5.51 Million | $117.39 Million | ▲ +5.2 pp |
| 2018 | 11.9% | $8.40 Million | $8.40 Million | $- | $70.64 Million | ▼ -24.6 pp |
| 2017 | 36.5% | $8.23 Million | $8.23 Million | $- | $22.56 Million | — |